http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101749004-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-48315 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-645 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-4823 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 |
| filingDate | 2014-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101749004-B1 |
| titleOfInvention | Pharmaceutical, water-soluble and antifungal macromolecular compound |
| abstract | The present invention relates to a water-soluble antifungal macromolecular compound for medicaments used for the treatment of infectious diseases, in particular a multijunction body comprising an active drug substance and a macromolecular polymer bound to each other via chemical bonding. The active drug substance is a polyenemercrolide compound such as amphotericin B. Methods for making such multijunctions, methods for increasing the solubility of active drug substances, and fungal infections such as sepsis, endocarditis, meningitis (caused by cryptococcosis and other fungi), abdominal infection ), Pulmonary infection, urinary tract infection, etc., are also provided. Multi-complexes have properties that are superior in terms of biological performance and / or physical and / or chemical performance. |
| priorityDate | 2013-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 113.